Convalescent plasma for covid-19

Opinion piece covers the FDA's emergency use protocol for convalescent plasma in COVID-19, highlighting the lack of current trial evidence. More widespread use outside of clinical trials may reduce the likelihood of answers to important therapeutic questions.

Source:

British Medical Journal